Richard Kevin

14PUBLICATIONS
30CO-AUTHORS
CybercrimeProteins and peptidesCharacterisation of biological macromoleculesBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 08, 2025
The driving-related attitudes, beliefs and behaviours of cannabis users in the Australian Capital Territory following decriminalisation.

Danielle McCartney, Cilla Zhou, Isobel Lavender

|Jun 24, 2024
Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA.

Eric Sparkes, Jack W Markham, Rochelle Boyd

|Dec 08, 2022
How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials.

Danielle McCartney, Richard C Kevin, Anastasia S Suraev

|Apr 20, 2022
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors.

Richard C Kevin, Somayeh Mirlohi, Jamie J Manning

|Apr 11, 2022
Defining Steric Requirements at CB1 and CB2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues.

Jack Markham, Eric Sparkes, Rochelle Boyd

|Mar 21, 2022
Structure-activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA.

Eric Sparkes, Elizabeth A Cairns, Richard C Kevin

Pageof 3

Frequent Collaborators

8 joint publications

Samuel D Banister

5 joint publications

Michelle Glass

5 joint publications

David E Hibbs

4 joint publications

Mark Connor